When Rachel Cooper, from South Wales, decided to use weight loss jabs to help her shed the extra pounds she'd piled on during ...

It has been a year since Ellen Ogley put down her Mounjaro pen after shedding 3st on what has been dubbed the 'King Kong' of ...

Novo Nordisk (NYSE:NVO) and Eli Lilly (NYSE:LLY) shares fell more than 4% each in premarket trading on Friday following comments from President Trump a day earlier regarding potential price reductions ...

The Boom That Built Billion-Dollar Empires GLP-1 drugs have reshaped the pharmaceutical landscape, turning obesity and ...

Eli Lilly shares fell over 3% in premarket trading after Trump signaled price cuts for weight loss drugs, sparking concerns ...

Shares of Eli Lilly and Novo Nordisk move lower in Thursday's after-hours session after President Trump indicated weight-loss ...

Mehmet Oz, head of the Centers for Medicare and Medicaid Services, said talks over the price of weight-loss drugs are still ...

Researchers say GLP-1 drugs prescribed for weight loss like Ozempic and Mounjaro are more effective at reducing heart health ...

Eli Lilly and Company's strong Phase 3 diabetes drug results boost its GLP-1 franchise. Click for my updated look at LLY ...

People are trying mini doses of GLP-1 drugs to lose weight or maintain weight loss, but doctors urge caution, calling the ...

Aspen to distribute Eli Lilly’s Mounjaro in South Africa • Launch heightens obesity drug rivalry with Novo Nordisk’s Wegovy • High costs limit access despite soaring demand and obesity rates South ...

Regardless of your investing knowledge or experience, you can't go wrong with these three behemoths in your portfolio.